Topical chemotherapy for ocular surface squamous neoplasia

Afshan Nanji, Fouad E. Sayyad, Carol L. Karp

Research output: Contribution to journalArticle

40 Citations (Scopus)

Abstract

PURPOSE OF REVIEW: Ocular surface squamous neoplasia (OSSN) is an umbrella term for a spectrum of epithelial dysplasias of the cornea, conjunctiva, and limbus. Treatment for OSSN has historically been surgery, but nonsurgical interventions have been increasingly adopted. Advantages of medical treatments include the ability to treat the entire ocular surface and prevention of surgical complications. RECENT FINDINGS: The primary medical treatments for OSSN include mitomycin C, 5-fluorouracil, and interferon α2b. Mitomycin C has been shown in studies to be highly effective but has short-term and long-term side-effects that may be intolerable. 5-Fluorouracil and interferon α2b have been found to be similar in efficacy to mitomycin, with interferon being extremely well tolerated in the majority of patients. Most recently, other chemotherapeutic agents have been tried for OSSN including antivascular endothelial growth factor agents and vitamin A. The data regarding these latter treatment strategies are still limited. SUMMARY: An understanding of the recent literature, with respect to the efficacy, advantages, and disadvantages of the various therapies for OSSN will allow us to tailor treatment to each patient.

Original languageEnglish (US)
Pages (from-to)336-342
Number of pages7
JournalCurrent Opinion in Ophthalmology
Volume24
Issue number4
DOIs
StatePublished - Jul 2013
Externally publishedYes

Fingerprint

Drug Therapy
Mitomycin
Interferons
Neoplasms
Fluorouracil
Therapeutics
Limbus Corneae
Endothelial Growth Factors
Conjunctiva
Vitamin A

Keywords

  • 5-fluorouracil
  • interferon
  • mitomycin C
  • ocular surface squamous neoplasia
  • topical chemotherapy

ASJC Scopus subject areas

  • Ophthalmology

Cite this

Topical chemotherapy for ocular surface squamous neoplasia. / Nanji, Afshan; Sayyad, Fouad E.; Karp, Carol L.

In: Current Opinion in Ophthalmology, Vol. 24, No. 4, 07.2013, p. 336-342.

Research output: Contribution to journalArticle

Nanji, Afshan ; Sayyad, Fouad E. ; Karp, Carol L. / Topical chemotherapy for ocular surface squamous neoplasia. In: Current Opinion in Ophthalmology. 2013 ; Vol. 24, No. 4. pp. 336-342.
@article{70860ac588804b419b75a77f500acdbf,
title = "Topical chemotherapy for ocular surface squamous neoplasia",
abstract = "PURPOSE OF REVIEW: Ocular surface squamous neoplasia (OSSN) is an umbrella term for a spectrum of epithelial dysplasias of the cornea, conjunctiva, and limbus. Treatment for OSSN has historically been surgery, but nonsurgical interventions have been increasingly adopted. Advantages of medical treatments include the ability to treat the entire ocular surface and prevention of surgical complications. RECENT FINDINGS: The primary medical treatments for OSSN include mitomycin C, 5-fluorouracil, and interferon α2b. Mitomycin C has been shown in studies to be highly effective but has short-term and long-term side-effects that may be intolerable. 5-Fluorouracil and interferon α2b have been found to be similar in efficacy to mitomycin, with interferon being extremely well tolerated in the majority of patients. Most recently, other chemotherapeutic agents have been tried for OSSN including antivascular endothelial growth factor agents and vitamin A. The data regarding these latter treatment strategies are still limited. SUMMARY: An understanding of the recent literature, with respect to the efficacy, advantages, and disadvantages of the various therapies for OSSN will allow us to tailor treatment to each patient.",
keywords = "5-fluorouracil, interferon, mitomycin C, ocular surface squamous neoplasia, topical chemotherapy",
author = "Afshan Nanji and Sayyad, {Fouad E.} and Karp, {Carol L.}",
year = "2013",
month = "7",
doi = "10.1097/ICU.0b013e3283622a13",
language = "English (US)",
volume = "24",
pages = "336--342",
journal = "Current Opinion in Ophthalmology",
issn = "1040-8738",
publisher = "Lippincott Williams and Wilkins",
number = "4",

}

TY - JOUR

T1 - Topical chemotherapy for ocular surface squamous neoplasia

AU - Nanji, Afshan

AU - Sayyad, Fouad E.

AU - Karp, Carol L.

PY - 2013/7

Y1 - 2013/7

N2 - PURPOSE OF REVIEW: Ocular surface squamous neoplasia (OSSN) is an umbrella term for a spectrum of epithelial dysplasias of the cornea, conjunctiva, and limbus. Treatment for OSSN has historically been surgery, but nonsurgical interventions have been increasingly adopted. Advantages of medical treatments include the ability to treat the entire ocular surface and prevention of surgical complications. RECENT FINDINGS: The primary medical treatments for OSSN include mitomycin C, 5-fluorouracil, and interferon α2b. Mitomycin C has been shown in studies to be highly effective but has short-term and long-term side-effects that may be intolerable. 5-Fluorouracil and interferon α2b have been found to be similar in efficacy to mitomycin, with interferon being extremely well tolerated in the majority of patients. Most recently, other chemotherapeutic agents have been tried for OSSN including antivascular endothelial growth factor agents and vitamin A. The data regarding these latter treatment strategies are still limited. SUMMARY: An understanding of the recent literature, with respect to the efficacy, advantages, and disadvantages of the various therapies for OSSN will allow us to tailor treatment to each patient.

AB - PURPOSE OF REVIEW: Ocular surface squamous neoplasia (OSSN) is an umbrella term for a spectrum of epithelial dysplasias of the cornea, conjunctiva, and limbus. Treatment for OSSN has historically been surgery, but nonsurgical interventions have been increasingly adopted. Advantages of medical treatments include the ability to treat the entire ocular surface and prevention of surgical complications. RECENT FINDINGS: The primary medical treatments for OSSN include mitomycin C, 5-fluorouracil, and interferon α2b. Mitomycin C has been shown in studies to be highly effective but has short-term and long-term side-effects that may be intolerable. 5-Fluorouracil and interferon α2b have been found to be similar in efficacy to mitomycin, with interferon being extremely well tolerated in the majority of patients. Most recently, other chemotherapeutic agents have been tried for OSSN including antivascular endothelial growth factor agents and vitamin A. The data regarding these latter treatment strategies are still limited. SUMMARY: An understanding of the recent literature, with respect to the efficacy, advantages, and disadvantages of the various therapies for OSSN will allow us to tailor treatment to each patient.

KW - 5-fluorouracil

KW - interferon

KW - mitomycin C

KW - ocular surface squamous neoplasia

KW - topical chemotherapy

UR - http://www.scopus.com/inward/record.url?scp=84880133204&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84880133204&partnerID=8YFLogxK

U2 - 10.1097/ICU.0b013e3283622a13

DO - 10.1097/ICU.0b013e3283622a13

M3 - Article

VL - 24

SP - 336

EP - 342

JO - Current Opinion in Ophthalmology

JF - Current Opinion in Ophthalmology

SN - 1040-8738

IS - 4

ER -